Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proton Pump Inhibitor (PPI) Inappropriate Use and Economic Burden in Chinese Population: A Descriptive Retrospective Observational Study Using Database

NCT03118778 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT03118778
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03118778 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proton Pump Inhibitor (PPI) Inappropriate Use and Economic Burden in Chinese Population: A Descriptive Retrospective Observational Study Using Database
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
April 28, 2017
Completion date
July 10, 2017
Enrollment
90,895 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal disease